Let’s Clear the Air in Cystic Fibrosis

Let’s Clear the Air in Cystic Fibrosis

Advancements in targeted gene therapy have given patients with cystic fibrosis a longer life expectancy. Take this course to learn about these advancements, supportive medication therapies, and opportunities to provide care to patients with CF. 

Upon successful completion of this knowledge-based CPE course, pharmacists should be able to:
1. Explain the pathophysiology of cystic fibrosis (CF) and the various organ systems impacted
2. Recognize medications commonly associated with CF and indication for use
3. Identify medications for symptom management and targeted gene therapies
4. Identify opportunities for pharmacists to intervene and enhance care in the inpatient and outpatient pharmacy setting
5. Assess the pharmacoeconomics and socioeconomic impact of the disease

Kelli Cunningham, PharmD, BCPS
Pediatric Specialist
Blank Children’s Hospital – Unity Point DM

Kelli Cunningham does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable
Initial Release Date: July 1, 2021
Planned Expiration Date: July 1, 2024

Copyright 2021, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

Universal Activity Number (UAN): 0107-0000-21-147-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


1h 0m

Topic Designator

Disease State/Drug Therapy



ACPE Topic

01 Drug Therapy





Release Date






ACPE Number


This course is in our subscription.